401 related articles for article (PubMed ID: 33982761)
1. Evaluation of the antimetastatic and anticancer activities of morin in HER2‑overexpressing breast cancer SK‑BR‑3 cells.
Lee KS; Lee MG; Nam KS
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 33982761
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of TPA‑induced metastatic potential by morin hydrate in MCF‑7 human breast cancer cells via the Akt/GSK‑3β/c‑Fos signaling pathway.
Lee KS; Nam GS; Baek J; Kim S; Nam KS
Int J Oncol; 2020 Feb; 56(2):630-640. PubMed ID: 31939617
[TBL] [Abstract][Full Text] [Related]
3. Morin, a flavonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB‑231 partly through suppression of the Akt pathway.
Jin H; Lee WS; Eun SY; Jung JH; Park HS; Kim G; Choi YH; Ryu CH; Jung JM; Hong SC; Shin SC; Kim HJ
Int J Oncol; 2014 Oct; 45(4):1629-37. PubMed ID: 24993541
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of the plant extract morin in tongue squamous cell carcinoma cells.
Ji Y; Jia L; Zhang Y; Xing Y; Wu X; Zhao B; Zhang D; Xu X; Qiao X
Oncol Rep; 2018 Nov; 40(5):3024-3032. PubMed ID: 30132559
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells.
Jin Q; Yuan LX; Boulbes D; Baek JM; Wang YN; Gomez-Cabello D; Hawke DH; Yeung SC; Lee MH; Hortobagyi GN; Hung MC; Esteva FJ
Breast Cancer Res; 2010; 12(6):R96. PubMed ID: 21080941
[TBL] [Abstract][Full Text] [Related]
6. Anticancer activity of pristimerin in epidermal growth factor receptor 2-positive SKBR3 human breast cancer cells.
Lee JS; Yoon IS; Lee MS; Cha EY; Thuong PT; Diep TT; Kim JR
Biol Pharm Bull; 2013; 36(2):316-25. PubMed ID: 23370361
[TBL] [Abstract][Full Text] [Related]
7. Morin Inhibits Proliferation, Migration, and Invasion of Bladder Cancer EJ Cells via Modulation of Signaling Pathways, Cell Cycle Regulators, and Transcription Factor-Mediated MMP-9 Expression.
Shin SS; Won SY; Noh DH; Hwang B; Kim WJ; Moon SK
Drug Dev Res; 2017 Mar; 78(2):81-90. PubMed ID: 28176369
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle arrest-mediated cell death by morin in MDA-MB-231 triple-negative breast cancer cells.
Maharjan S; Kwon YS; Lee MG; Lee KS; Nam KS
Pharmacol Rep; 2021 Oct; 73(5):1315-1327. PubMed ID: 33993438
[TBL] [Abstract][Full Text] [Related]
9.
Jabeen A; Sharma A; Gupta I; Kheraldine H; Vranic S; Al Moustafa AE; Al Farsi HF
Molecules; 2020 Sep; 25(18):. PubMed ID: 32947764
[No Abstract] [Full Text] [Related]
10. Apigenin induces caspase-dependent apoptosis by inhibiting signal transducer and activator of transcription 3 signaling in HER2-overexpressing SKBR3 breast cancer cells.
Seo HS; Ku JM; Choi HS; Woo JK; Jang BH; Go H; Shin YC; Ko SG
Mol Med Rep; 2015 Aug; 12(2):2977-84. PubMed ID: 25936427
[TBL] [Abstract][Full Text] [Related]
11. Arctigenin-mediated cell death of SK-BR-3 cells is caused by HER2 inhibition and autophagy-linked apoptosis.
Lee MG; Lee KS; Nam KS
Pharmacol Rep; 2021 Apr; 73(2):629-641. PubMed ID: 33677703
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets.
Nava M; Dutta P; Zemke NR; Farias-Eisner R; Vadgama JV; Wu Y
BMC Med Genomics; 2019 Feb; 12(1):32. PubMed ID: 30736768
[TBL] [Abstract][Full Text] [Related]
13. Suppression of MMP-9 and FAK expression by pomolic acid via blocking of NF-κB/ERK/mTOR signaling pathways in growth factor-stimulated human breast cancer cells.
Park JH; Cho YY; Yoon SW; Park B
Int J Oncol; 2016 Sep; 49(3):1230-40. PubMed ID: 27573547
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.
Peng B; He R; Xu Q; Yang Y; Hu Q; Hou H; Liu X; Li J
Pharmacol Res; 2019 Apr; 142():1-13. PubMed ID: 30735802
[TBL] [Abstract][Full Text] [Related]
15. CK0403, a 9‑aminoacridine, is a potent anti‑cancer agent in human breast cancer cells.
Sun YW; Chen KY; Kwon CH; Chen KM
Mol Med Rep; 2016 Jan; 13(1):933-8. PubMed ID: 26648164
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells.
Vazquez-Martin A; Colomer R; Brunet J; Menendez JA
Int J Oncol; 2007 Oct; 31(4):769-76. PubMed ID: 17786307
[TBL] [Abstract][Full Text] [Related]
17. Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-
Sun X; Chang X; Wang Y; Xu B; Cao X
Biomed Res Int; 2019; 2019():9241769. PubMed ID: 31341911
[TBL] [Abstract][Full Text] [Related]
18. Alpinetin inhibits proliferation and migration of ovarian cancer cells via suppression of STAT3 signaling.
Zhao X; Guo X; Shen J; Hua D
Mol Med Rep; 2018 Oct; 18(4):4030-4036. PubMed ID: 30132572
[TBL] [Abstract][Full Text] [Related]
19. Rubioncolin C, a natural naphthohydroquinone dimer isolated from Rubia yunnanensis, inhibits the proliferation and metastasis by inducing ROS-mediated apoptotic and autophagic cell death in triple-negative breast cancer cells.
Li L; Wang J; Feng L; Fan J; Wang J; Tan N; Wang Z
J Ethnopharmacol; 2021 Sep; 277():114184. PubMed ID: 33961996
[TBL] [Abstract][Full Text] [Related]
20. Cytosolic phospholipase A2 activation correlates with HER2 overexpression and mediates estrogen-dependent breast cancer cell growth.
Caiazza F; Harvey BJ; Thomas W
Mol Endocrinol; 2010 May; 24(5):953-68. PubMed ID: 20211985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
